HomeLJUIF • OTCMKTS
add
SSY Group Ltd
Previous close
$0.70
Year range
$0.70 - $0.70
Market cap
11.03B HKD
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (HKD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.67B | 0.17% |
Operating expense | 491.78M | -14.64% |
Net income | 342.87M | 7.38% |
Net profit margin | 20.54 | 7.20% |
Earnings per share | — | — |
EBITDA | 542.58M | 10.12% |
Effective tax rate | 15.28% | — |
Balance Sheet
Total assets
Total liabilities
| (HKD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.61B | -10.24% |
Total assets | 12.55B | 10.74% |
Total liabilities | 4.98B | 7.06% |
Total equity | 7.57B | — |
Shares outstanding | 2.97B | — |
Price to book | 0.29 | — |
Return on assets | 8.57% | — |
Return on capital | 9.61% | — |
Cash Flow
Net change in cash
| (HKD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 342.87M | 7.38% |
Cash from operations | 161.46M | -30.35% |
Cash from investing | -144.00M | -8.52% |
Cash from financing | -34.51M | -179.29% |
Net change in cash | -25.34M | -141.51% |
Free cash flow | 218.66M | 31.59% |
About
Lijun International Pharmaceutical (Holding) Co., Limited is a Wanchai, Hong Kong–based investment holding company with two pharmaceutical business segments: Wikipedia
Founded
1999
Website
Employees
5,800
